Educational attainment of individuals with lymphangioleiomyomatosis is a determinant of timely diagnosis and treatment uptake
Abstract Background Lymphangioleiomyomatosis (LAM) is a rare, progressive lung disease predominantly affecting women. Despite the availability of FDA-approved treatments, mTOR inhibitors like sirolimus or everolimus, significant disparities persist in early diagnosis, treatment utilization, and pati...
Sábháilte in:
| Príomhchruthaitheoir: | |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
BMC
2026-02-01
|
| Sraith: | Orphanet Journal of Rare Diseases |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1186/s13023-026-04284-8 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|